Intravenous(IV) Therapy and Vein Access Market - Global Outlook and Forecast 2023-2027

Report ID: 925441 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Intravenous(IV) Therapy and Vein Access Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Intravenous(IV) Therapy and Vein Access Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Intravenous(IV) Therapy and Vein Access Overall Market Size
    2.1 Global Intravenous(IV) Therapy and Vein Access Market Size: 2021 VS 2027
    2.2 Global Intravenous(IV) Therapy and Vein Access Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Intravenous(IV) Therapy and Vein Access Players in Global Market
    3.2 Top Global Intravenous(IV) Therapy and Vein Access Companies Ranked by Revenue
    3.3 Global Intravenous(IV) Therapy and Vein Access Revenue by Companies
    3.4 Top 3 and Top 5 Intravenous(IV) Therapy and Vein Access Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Intravenous(IV) Therapy and Vein Access Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Intravenous(IV) Therapy and Vein Access Players in Global Market
        3.6.1 List of Global Tier 1 Intravenous(IV) Therapy and Vein Access Companies
        3.6.2 List of Global Tier 2 and Tier 3 Intravenous(IV) Therapy and Vein Access Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Intravenous(IV) Therapy and Vein Access Market Size Markets, 2021 & 2027
        4.1.2 Infusion Pumps
        4.1.3 Implantable Ports
        4.1.4 Intravenous Catheters
        4.1.5 Hypodermic Needles
        4.1.6 Other
    4.2 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue & Forecasts
        4.2.1 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue, 2016-2021
        4.2.2 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue, 2022-2027
        4.2.3 By Type - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Intravenous(IV) Therapy and Vein Access Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Clinics
        5.1.4 Other
    5.2 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue & Forecasts
        5.2.1 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue, 2016-2021
        5.2.2 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue, 2022-2027
        5.2.3 By Application - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Intravenous(IV) Therapy and Vein Access Market Size, 2021 & 2027
    6.2 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue & Forecasts
        6.2.1 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue, 2016-2021
        6.2.2 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue, 2022-2027
        6.2.3 By Region - Global Intravenous(IV) Therapy and Vein Access Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Intravenous(IV) Therapy and Vein Access Revenue, 2016-2027
        6.3.2 US Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.3.3 Canada Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.3.4 Mexico Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Intravenous(IV) Therapy and Vein Access Revenue, 2016-2027
        6.4.2 Germany Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.4.3 France Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.4.4 U.K. Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.4.5 Italy Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.4.6 Russia Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.4.7 Nordic Countries Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.4.8 Benelux Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Intravenous(IV) Therapy and Vein Access Revenue, 2016-2027
        6.5.2 China Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.5.3 Japan Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.5.4 South Korea Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.5.5 Southeast Asia Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.5.6 India Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Intravenous(IV) Therapy and Vein Access Revenue, 2016-2027
        6.6.2 Brazil Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.6.3 Argentina Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Intravenous(IV) Therapy and Vein Access Revenue, 2016-2027
        6.7.2 Turkey Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.7.3 Israel Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.7.4 Saudi Arabia Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
        6.7.5 UAE Intravenous(IV) Therapy and Vein Access Market Size, 2016-2027
7 Players Profiles
    7.1 B. Braun
        7.1.1 B. Braun Corporate Summary
        7.1.2 B. Braun Business Overview
        7.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.1.5 B. Braun Key News
    7.2 Baxter International
        7.2.1 Baxter International Corporate Summary
        7.2.2 Baxter International Business Overview
        7.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.2.5 Baxter International Key News
    7.3 Becton Dickinson
        7.3.1 Becton Dickinson Corporate Summary
        7.3.2 Becton Dickinson Business Overview
        7.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.3.5 Becton Dickinson Key News
    7.4 C. R. Bard
        7.4.1 C. R. Bard Corporate Summary
        7.4.2 C. R. Bard Business Overview
        7.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.4.5 C. R. Bard Key News
    7.5 Fresenius Kabi
        7.5.1 Fresenius Kabi Corporate Summary
        7.5.2 Fresenius Kabi Business Overview
        7.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.5.5 Fresenius Kabi Key News
    7.6 Hospira(ICU Medical)
        7.6.1 Hospira(ICU Medical) Corporate Summary
        7.6.2 Hospira(ICU Medical) Business Overview
        7.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.6.5 Hospira(ICU Medical) Key News
    7.7 Medtronic
        7.7.1 Medtronic Corporate Summary
        7.7.2 Medtronic Business Overview
        7.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.4.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.7.5 Medtronic Key News
    7.8 Smiths Group
        7.8.1 Smiths Group Corporate Summary
        7.8.2 Smiths Group Business Overview
        7.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.8.5 Smiths Group Key News
    7.9 Teleflex
        7.9.1 Teleflex Corporate Summary
        7.9.2 Teleflex Business Overview
        7.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Major Product Offerings
        7.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue in Global (2016-2021)
        7.9.5 Teleflex Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
104
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Intravenous Therapy and Vein Access Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Intravenous Therapy and Vein Access Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Intravenous Therapy and Vein Access Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports